March 5, 2019 10:50 AM ESTUpdated April 18, 11:45 AM
People

Was As­traZeneca CEO Pas­cal So­ri­ot hap­py with his $14.8M in '18 com­pen­sa­tion? Prob­a­bly not so much

John Carroll

Editor & Founder

As­traZeneca CEO Pas­cal So­ri­ot made head­lines when he moaned about the poor pay he took home for 2017, forced to live on about $13 mil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times